Bebtelovimab

Bebtelovimab is a highly specialized research tool designed to recognize and neutralize the spike protein of the SARS-CoV-2 virus, which causes COVID-19. The spike protein is a key part of the virus that allows it to enter human cells by attaching to a specific receptor on the cell surface. This antibody works by binding to the spike protein, blocking the virus from entering cells and helping to trigger the body’s immune response.

Cat. No: 14504

Sizes : 100 µg
1 mg

Ask For Details

Category: Biosimilars

Description
Download Manuals

Description

Target	SARS-CoV-2 Spike Protein
Clonality	Monoclonal
Reactivity	Virus
Host	Human
Recommended dilutions	Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Isotype	IgG₁ Lambda
Form	Liquid
Purity	> 95%
Purification	Purified by Protein A or G.
Storage	Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Buffer	PBS, pH 7.4.
Concentration	1.93 mg/ml
Availability	Shipped within 1-3 working days.
Note	This product is for research use only.
Directions for use	Centrifuge before opening to ensure complete recovery of vial contents.